420 related articles for article (PubMed ID: 23419384)
21. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
22. Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).
Berens S; Stroe-Kunold E; Kraus F; Tesarz J; Gauss A; Niesler B; Herzog W; Schaefert R
J Psychosom Res; 2018 Feb; 105():72-79. PubMed ID: 29332637
[TBL] [Abstract][Full Text] [Related]
23. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
25. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS).
Lindfors P; Törnblom H; Sadik R; Björnsson ES; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2012 Dec; 47(12):1480-7. PubMed ID: 23094932
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
27. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.
Peters SL; Yao CK; Philpott H; Yelland GW; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2016 Sep; 44(5):447-59. PubMed ID: 27397586
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
Flik CE; Laan W; Zuithoff NPA; van Rood YR; Smout AJPM; Weusten BLAM; Whorwell PJ; de Wit NJ
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):20-31. PubMed ID: 30473202
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
van der Veek PP; van Rood YR; Masclee AA
Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ
Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
[TBL] [Abstract][Full Text] [Related]
32. The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.
Peter J; Tran US; Michalski M; Moser G
PLoS One; 2018; 13(11):e0202538. PubMed ID: 30419026
[TBL] [Abstract][Full Text] [Related]
33. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial.
Shinozaki M; Kanazawa M; Kano M; Endo Y; Nakaya N; Hongo M; Fukudo S
Appl Psychophysiol Biofeedback; 2010 Sep; 35(3):189-98. PubMed ID: 19997775
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
36. Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
Rutten JMTM; Vlieger AM; Frankenhuis C; George EK; Groeneweg M; Norbruis OF; Tjon A Ten W; van Wering HM; Dijkgraaf MGW; Merkus MP; Benninga MA
JAMA Pediatr; 2017 May; 171(5):470-477. PubMed ID: 28346581
[TBL] [Abstract][Full Text] [Related]
37. Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects.
Johannesson E; Ringström G; Abrahamsson H; Sadik R
World J Gastroenterol; 2015 Jan; 21(2):600-8. PubMed ID: 25593485
[TBL] [Abstract][Full Text] [Related]
38. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
Kearney DJ; McDermott K; Martinez M; Simpson TL
Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
[TBL] [Abstract][Full Text] [Related]
39. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
